COMMUNIQUÉS West-GlobeNewswire

Result of Annual General Meeting
31/05/2019
NEW YORK, May 31, 2019 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, announces that at the Annual General Meeting held [...]
Olainfarm Group’s revenue in the first quarter reaches 34.7 million EUR; net profit tops 8.3 million EUR
31/05/2019
During the 1st quarter of 2019, consolidated sales of the Olainfarm Group reached 34.7 million euros which is an increase by 4 million euros or 13% if compared to similar period of 2018. Such result marks a new record [...]
XBiotech annonce une offre publique pour l'émission d'actions ordinaires
31/05/2019
AUSTIN, Texas, 31 mai 2019 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ : XBIT) a annoncé aujourd'hui l'amorcement d'une offre publique souscrite pour l'émission d'actions ordinaires, sous réserve des conditions du marché [...]
Generex Biotechnology Announces Share Dividend & Strategic Plans
31/05/2019
MIRAMAR, Fla., May 31, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) is pleased to announce that the company plans to declare [...]
WW Prepays Portion of Term Loan Facility
31/05/2019
NEW YORK, May 31, 2019 (GLOBE NEWSWIRE) -- On May 31, 2019, Weight Watchers International, Inc. (NASDAQ: WW) voluntarily prepaid $50 million of term loans outstanding under its credit agreement. After giving effect to [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 avril 2019
31/05/2019
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF, les sociétés dont [...]
XBiotech Announces Pricing of Public Offering of Common Shares
31/05/2019
AUSTIN, Texas, May 31, 2019 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) today announced the pricing of an underwritten public offering of 4,848,485 of its common shares at a public offering price of $8.25 per share [...]
Golden Leaf Holdings Reports Fiscal First Quarter 2019 Results
31/05/2019
TORONTO, May 31, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a pioneer cannabis oil solutions company and dispensary operator built around recognized [...]
LC-SCRUM Japan Expands Genomic Screening Project to Taiwan and Establishes LC-SCRUM Asia
31/05/2019
TOKYO, May 31, 2019 (GLOBE NEWSWIRE) -- The National Cancer Center of Japan (“NCC”) today announced the signing of a collaboration between its Cancer Genomic Screening Project for Individualized Medicine (“LC-SCRUM”) [...]
Emerald Health Therapeutics Reports First Quarter 2019 Financial Results; Demonstrates Continued Growth in Sales
31/05/2019
Emerald sales up 131% quarter-over-quarter VANCOUVER, British Columbia, May 31, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today reported financial results for the [...]
Kite and Humanigen Announce Clinical Collaboration to Evaluate Investigational Combination of Yescarta® (axicabtagene ciloleucel) With lenzilumab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
31/05/2019
-- Phase 1/2 Multi-Center Clinical Trial to Begin Enrolling in Q4 2019 -- SANTA MONICA, Calif. and BURLINGAME, Calif., May 31, 2019 (GLOBE NEWSWIRE) -- Kite, a Gilead Company (Nasdaq: GILD) and Humanigen, Inc., (HGEN) [...]
Acer Therapeutics Announces Poster Presentation at Society for Vascular Medicine Annual Meeting
31/05/2019
Pilot study using claims database suggests that a minority of U.S. vEDS patients (34%) are being treated with antihypertensive medications Data show no significant difference in clinical event rates in vEDS patients [...]
Turning Point Therapeutics Announces Updated Interim Clinical Data of Repotrectinib in Advanced ROS1+ Non-Small Cell Lung Cancer
31/05/2019
In TKI-naïve ROS1+ Patients, Overall Response Rate by Blinded Review is 82 Percent, and 83 Percent at Likely Recommended Phase 2 Dose of 160 mg QD or Above; Median Duration of Response across all Dose Levels Not Yet [...]
Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Gene Therapy as Potential Cancer Treatment
31/05/2019
NEW YORK, May 31, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – Genprex Inc. (NASDAQ:GNPX) announces the availability of a NetworkNewsAudio publication titled, “Biotechs That Successfully Combat Cancer Could See [...]
Ultragenyx to Present at Upcoming Investor Conferences
31/05/2019
NOVATO, Calif., May 31, 2019 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases, [...]
Surgery Partners, Inc. to Present at the Jefferies 2019 Global Healthcare Conference
31/05/2019
BRENTWOOD, Tenn., May 31, 2019 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced that management will present at the [...]
Aura Announces Appointment of Al Quong to Its Board of Directors
31/05/2019
TORONTO, May 31, 2019 (GLOBE NEWSWIRE) -- Aura Health Inc. (the " Company " or “ Aura ”) ( CSE:BUZZ ) is pleased to announce the appointment of Al Quong to its board of directors, subject to regulatory approval. Mr. [...]
Allscripts to present at upcoming investor events
31/05/2019
CHICAGO, May 31, 2019 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX) today announced that certain members of its management team will present at the following upcoming investor events: Baird 2019 Global Consumer, [...]
Helsinn Group Announces Upcoming Presentation of Phase 3b data of NEPA (fosnetupitant / palonosetron) IV at ASCO 2019
31/05/2019
Helsinn Group Announces Upcoming Presentation of Phase 3b data of NEPA (fosnetupitant / palonosetron) IV at ASCO 2019 The NEPA IV formulation was evaluated for safety in the AC setting. Lugano, Switzerland, May 31, 2019 [...]

Pages